221 related articles for article (PubMed ID: 31468394)
1. Role of Taurine in Testicular Function in the Fragile x Mouse.
Lin S; El Idrissi A
Adv Exp Med Biol; 2019; 1155():155-162. PubMed ID: 31468394
[TBL] [Abstract][Full Text] [Related]
2. Taurine regulation of short term synaptic plasticity in fragile X mice.
El Idrissi A; Neuwirth LS; L'Amoreaux W
J Biomed Sci; 2010 Aug; 17 Suppl 1(Suppl 1):S15. PubMed ID: 20804589
[TBL] [Abstract][Full Text] [Related]
3. Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium.
Cell; 1994 Jul; 78(1):23-33. PubMed ID: 8033209
[TBL] [Abstract][Full Text] [Related]
4. Macroorchidism in FMR1 knockout mice is caused by increased Sertoli cell proliferation during testicular development.
Slegtenhorst-Eegdeman KE; de Rooij DG; Verhoef-Post M; van de Kant HJ; Bakker CE; Oostra BA; Grootegoed JA; Themmen AP
Endocrinology; 1998 Jan; 139(1):156-62. PubMed ID: 9421410
[TBL] [Abstract][Full Text] [Related]
5. Neuro-endocrine basis for altered plasma glucose homeostasis in the Fragile X mouse.
El Idrissi A; Yan X; Sidime F; L'Amoreaux W
J Biomed Sci; 2010 Aug; 17 Suppl 1(Suppl 1):S8. PubMed ID: 20804628
[TBL] [Abstract][Full Text] [Related]
6. (Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features.
Peier AM; McIlwain KL; Kenneson A; Warren ST; Paylor R; Nelson DL
Hum Mol Genet; 2000 May; 9(8):1145-59. PubMed ID: 10767339
[TBL] [Abstract][Full Text] [Related]
7. Whole genome microarray analysis of gene expression in subjects with fragile X syndrome.
Bittel DC; Kibiryeva N; Butler MG
Genet Med; 2007 Jul; 9(7):464-72. PubMed ID: 17666893
[TBL] [Abstract][Full Text] [Related]
8. Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency.
Buijsen RA; Visser JA; Kramer P; Severijnen EA; Gearing M; Charlet-Berguerand N; Sherman SL; Berman RF; Willemsen R; Hukema RK
Hum Reprod; 2016 Jan; 31(1):158-68. PubMed ID: 26537920
[TBL] [Abstract][Full Text] [Related]
9. Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome.
Gruss M; Braun K
Neural Plast; 2001; 8(4):285-98. PubMed ID: 12018775
[TBL] [Abstract][Full Text] [Related]
10. FMRP Expression Levels in Mouse Central Nervous System Neurons Determine Behavioral Phenotype.
Arsenault J; Gholizadeh S; Niibori Y; Pacey LK; Halder SK; Koxhioni E; Konno A; Hirai H; Hampson DR
Hum Gene Ther; 2016 Dec; 27(12):982-996. PubMed ID: 27604541
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
[TBL] [Abstract][Full Text] [Related]
12. Genetic deletion of regulator of G-protein signaling 4 (RGS4) rescues a subset of fragile X related phenotypes in the FMR1 knockout mouse.
Pacey LK; Doss L; Cifelli C; van der Kooy D; Heximer SP; Hampson DR
Mol Cell Neurosci; 2011 Mar; 46(3):563-72. PubMed ID: 21215802
[TBL] [Abstract][Full Text] [Related]
13. Learning and behavioral deficits associated with the absence of the fragile X mental retardation protein: what a fly and mouse model can teach us.
Santos AR; Kanellopoulos AK; Bagni C
Learn Mem; 2014 Oct; 21(10):543-55. PubMed ID: 25227249
[TBL] [Abstract][Full Text] [Related]
14. Synaptic vesicle dynamic changes in a model of fragile X.
Broek JAC; Lin Z; de Gruiter HM; van 't Spijker H; Haasdijk ED; Cox D; Ozcan S; van Cappellen GWA; Houtsmuller AB; Willemsen R; de Zeeuw CI; Bahn S
Mol Autism; 2016; 7():17. PubMed ID: 26933487
[TBL] [Abstract][Full Text] [Related]
15. microRNAs and Fragile X Syndrome.
Lin SL
Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
[TBL] [Abstract][Full Text] [Related]
16. Effects of a social stimulus on gene expression in a mouse model of fragile X syndrome.
Rogers TD; Anacker AMJ; Kerr TM; Forsberg CG; Wang J; Zhang B; Veenstra-VanderWeele J
Mol Autism; 2017; 8():30. PubMed ID: 28649315
[TBL] [Abstract][Full Text] [Related]
17. Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation.
Qin M; Kang J; Smith CB
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15758-63. PubMed ID: 12427968
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome.
Romero-Zerbo Y; Decara J; el Bekay R; Sanchez-Salido L; Del Arco-Herrera I; de Fonseca FR; de Diego-Otero Y
J Pineal Res; 2009 Mar; 46(2):224-34. PubMed ID: 19141086
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of Autism-associated genes in the brain of Fragile X mouse model.
Zhang A; Shen CH; Ma SY; Ke Y; El Idrissi A
Biochem Biophys Res Commun; 2009 Feb; 379(4):920-3. PubMed ID: 19138667
[TBL] [Abstract][Full Text] [Related]
20. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.
Spencer CM; Serysheva E; Yuva-Paylor LA; Oostra BA; Nelson DL; Paylor R
Hum Mol Genet; 2006 Jun; 15(12):1984-94. PubMed ID: 16675531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
